Nano-X Imaging (NASDAQ:NNOX) Given Overweight Rating at Cantor Fitzgerald

Key Points

• Cantor Fitzgerald reiterated an “overweight” rating on Nano-X Imaging and maintained a $5.00 price target, implying roughly 401% upside from the prior close.
• Analyst sentiment remains mixed, but MarketBeat reports a consensus “Moderate Buy” rating and an average target price of $4.33.
• Nano-X reported a quarterly loss of $0.16 per share on $4.31 million in revenue, while insiders purchased 95,443 shares worth approximately $89,706 over the past 90 days.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report)'s stock had its "overweight" rating reiterated by Cantor Fitzgerald in a research note issued to investors on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. Cantor Fitzgerald's target price indicates a potential upside of 401.15% from the company's previous close.

• Nano-X Imaging NASDAQ: NNOX Stock: Reimagining the X-Ray

Several other equities analysts also recently weighed in on the company. Weiss Ratings reiterated a "sell (e+)" rating on shares of Nano-X Imaging in a research report on Wednesday, July 8th. Alliance Global Partners cut Nano-X Imaging from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $5.00 to $3.00 in a research report on Tuesday, July 7th. D. Boral Capital reaffirmed a "buy" rating and issued a $5.00 price objective on shares of Nano-X Imaging in a research note on Monday, April 20th. Finally, Zacks Research raised Nano-X Imaging from a "strong sell" rating to a "hold" rating in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $4.33.

Nano-X Imaging Stock Performance

NNOX opened at $1.00 on Monday. The firm's 50 day simple moving average is $1.23 and its two-hundred day simple moving average is $1.89. The company has a market capitalization of $69.90 million, a PE ratio of -0.63 and a beta of 1.27. Nano-X Imaging has a 1-year low of $0.73 and a 1-year high of $4.71.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last issued its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) earnings per share (EPS) for the quarter. The business had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. Equities analysts forecast that Nano-X Imaging will post -0.6 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Erez Meltzer acquired 36,000 shares of Nano-X Imaging stock in a transaction dated Monday, July 27th. The shares were purchased at an average price of $0.93 per share, for a total transaction of $33,480.00. Following the completion of the transaction, the chief executive officer directly owned 36,000 shares in the company, valued at approximately $33,480. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Dan S. Suesskind purchased 50,000 shares of Nano-X Imaging stock in a transaction on Monday, July 27th. The stock was bought at an average price of $0.93 per share, for a total transaction of $46,500.00. Following the completion of the acquisition, the director owned 50,000 shares in the company, valued at $46,500. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have acquired 95,443 shares of company stock valued at $89,706.

Hedge Funds Weigh In On Nano-X Imaging

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Kestra Advisory Services LLC bought a new position in shares of Nano-X Imaging in the 1st quarter valued at about $26,000. Independent Financial Group LLC purchased a new stake in Nano-X Imaging during the first quarter valued at approximately $26,000. Interchange Capital Partners LLC purchased a new stake in Nano-X Imaging during the fourth quarter valued at approximately $28,000. Aristides Capital LLC bought a new stake in shares of Nano-X Imaging in the 4th quarter valued at approximately $30,000. Finally, Hsbc Holdings PLC bought a new stake in shares of Nano-X Imaging in the 1st quarter valued at approximately $35,000. 21.49% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source